← Back to Search

Travel App for Improving College Commuting Habits (CTRAVELAPP Trial)

N/A
Waitlist Available
Led By John L Renne, PhD
Research Sponsored by Florida Atlantic University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one academic year
Awards & highlights

CTRAVELAPP Trial Summary

This trial will test whether providing information, marketing, and incentives to students can change their travel behavior to campus.

Who is the study for?
This trial is for off-campus students at FAU, BC, or PBSC who'll be at the same school next year. It's not for those living on campus or planning to leave their current college within a year.Check my eligibility
What is being tested?
The study tests if a travel app (MaaS) affects how college students commute to campus compared to no app use. It uses marketing and incentives in a randomized controlled setup.See study design
What are the potential side effects?
Since this isn't a medical trial, there aren't physical side effects. However, using the app may change travel habits or influence time management for commuting students.

CTRAVELAPP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one academic year
This trial's timeline: 3 weeks for screening, Varies for treatment, and one academic year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of students who make more frequent use of alternative modes to campus are associated with increased grade point averages.
Number of students who make more frequent use of alternative modes to campus are associated with increases in credit hours earned.
The rate of students using alternative modes increases.
Secondary outcome measures
Number of students who make more frequent use of alternative modes to campus are associated with increases in degree completion.
Number of students who make more frequent use of alternative modes to campus are associated with increases in retention.
The rate of students who own vehicles should decrease.
Other outcome measures
Self-Reported BMI
Self-reported general health

CTRAVELAPP Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: MaaS appActive Control1 Intervention
The Mobility-as-a-Service (MaaS) App will be provided to students in the Intervention Group and is intended to facilitate their use of alternative transportation modes such as public transit, ride-hailing, walking, biking, bike share, and e-scooter share to get to campus. The MaaS App will be downloaded to students' smartphones and will provide real-time, multimodal trip planning to students on demand when they open the app. This means, for instance, that a student can plan a trip that includes driving to a train station, taking the train, and then walking from the alighting train station to their final destination. The app will be white label, i.e. it will have a customized look and feel specific to the participating south Florida colleges, and it will have personalization features so that students can tailor the app to their travel patterns. Students in a cluster assigned to the MaaS group will also receive information concerning housing options. Students complete surveys
Group II: No appPlacebo Group1 Intervention
Students receive no app, no housing information, students complete surveys.

Find a Location

Who is running the clinical trial?

Florida Atlantic UniversityLead Sponsor
29 Previous Clinical Trials
9,279 Total Patients Enrolled
John L Renne, PhDPrincipal InvestigatorFlorida Atlantic University

Media Library

MaaS app Clinical Trial Eligibility Overview. Trial Name: NCT04720300 — N/A
Health Behaviors Clinical Trial 2023: MaaS app Highlights & Side Effects. Trial Name: NCT04720300 — N/A
Health Behaviors Research Study Groups: No app, MaaS app
MaaS app 2023 Treatment Timeline for Medical Study. Trial Name: NCT04720300 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~142 spots leftby Apr 2025